|

QX1206 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • 1Globe Health Institute1

Indications

  • Liver Disease1
  • Non-alcoholic Fatty Liver Disease NAFLD1
  • Type 2 Diabetes Mellitus (T2DM)1
  • Diabetes1

Other1 trial

A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.